NEWS CENTER

One Nucleus and British-Quebec Business Coalition sign Collaboration Agreement

19th February 2018

One Nucleus is delighted to announce that at the recent Genesis conference we entered into a Collaboration Agreement with the British-Quebec Business Coalition (BQBC).

Both One Nucleus and BQBC were established to help their member organisations maximise their success. BQBC is a leading organisation promoting two-way trade and investment between Britain and Quebec. Quebec possesses many centres of excellence with which One Nucleus members seek to build partnerships such as Genome Quebec, the first BQBC member to benefit under this collaboration.

Under the terms of the collaboration, non-UK based BQBC members can benefit from One Nucleus membership at a ‘Small Company’ rate, engagement in joint activities around global events, face to face engagement when visiting the One Nucleus region, event speaking opportunities and more. In return, One Nucleus members can join BQBC at their ‘Small Company’ rate, raising their profile to the BQBC membership in a reciprocal manner.

Tony Jones, CEO of One Nucleus commented “The international connectivity and opportunity awareness raising we are able to facilitate through such collaborations can be extremely valuable for our members as they strive to be globally competitive. I am delighted BQBC has selected One Nucleus as a partner to enhance their offer to their Life Science and Healthcare members seeking to enter the UK

Marilyn Krelenbaum, Vice President, Life Sciences, British Québec Business Coalition commented “I am delighted to sign this MOU between One Nucleus and BQBC, formalizing a collaboration that offers significant benefits to members of both organizations for greater visibility and access to the other market and opportunities for an expanded client base and value-added partnerships.”

Contact details:

One Nucleus                                                              British-Quebec Business Coalition

Tony Jones                                                                    Marilyn Krelenbaum

Email: tony@onenucleus.com                                  Email: marilynkrelenbaum@yahoo.ca

Tel: +44 (0)1223 896463                                           Tel: +1 514-488-2772

Notes to Editors:

About One Nucleus

Established in 1997, One Nucleus is the not-for-profit Life Sciences & Healthcare membership organisation centred on the London-Cambridge-East of England corridor. Headquartered in Cambridge, at the heart of Europe’s largest Life Sciences & Healthcare cluster, we support those institutions, companies and individuals undertaking activity in or with the above region.

Through providing local, UK-wide and international connectivity, One Nucleus seeks to enable our members to maximise their performance. This support helping them achieve, or better still exceed, the goals they have set for themselves. Biomedical and Healthcare R&D have always been impactful in driving social and economic progress. In an increasingly outsourced, collaborative and multi-disciplinary sector, bringing the best people together is key to translating great innovation into great products that markedly improve patient outcomes and drive economic development. Attracting and enabling the best people to engage with is at the heart of the One Nucleus team ethos and what we continually strive to deliver. Website: www.onenucleus.com

About British-Quebec Business Coalition

BQBC aims to be an important medium for the promotion of two-way trade and investment between Quebec and Great Britain.

BQBC aims to provide a forum for British companies seeking to develop their business in Quebec and Quebec companies seeking to develop their business in Great Britain.

BQBC will provide an infrastructure for its members to gain business referrals and to act as a conduit for trade between North America and Europe.

BQBC will leverage UK-Canadian agreements, as well as separate British-Quebec initiatives, to promote technology transfer and investment between Britain and Quebec.

BQBC will support trade missions performed by both British and Quebec Governments.

BQBC will seek partnerships, collaborators, distributors and agents within both markets to support members through its extensive network of contacts. Website: www.http://bqbc.org/

BRITISH QUEBEC BUSINESS COALITON COMMENTS ON LEAVE VOTE

After British voters shocked the world by voting for the UK to exit the European Union, many wonder what will happen to businesses that opened offices in London precisely to have access to the EU’s 27-country market. There is a lot of “noise” through various media. But what does all this mean?

Although the turbulence in the markets appears to have subsided, political instability and the possibility of a UK recession loom large within the business community. The resignation of the Prime Minister, the withdrawal of Boris Johnson from the Tory leadership race and a potential legal challenge to the use of article 50 by the UK government only add to the confusion.

One fear is that those global corporations will no longer see the benefit of remaining in the UK, opting to move their operations there to mainland Europe or Dublin. The media is rife with reports that firms are looking to Paris, Dublin or Frankfurt while there have been rumors that point to that, the reality is that the corporations – shocked by the vote result just like everyone else – are only beginning to analyze their options.

“These companies used London as a base to do business in Europe. Being based in a member-country of the EU allowed them to access to move goods and services freely through 27 markets,” says Peter Villani, President of the BQBC. “But now those companies may, until a new trade arrangement is entered into face new borders and tariffs if they want access to the EU. This does create a lot of uncertainty.” In addition, the loss of freedom of movement for EU citizens to the UK may disrupt certain key sectors of the economy in the UK.

Finally, what of the future of the Comprehensive Economic and Trade Agreement between Canada and the EU.? Will the exiting of the UK from the EU speed up or slow down its ratification by the remaining EU Member States? Will the UK push for a free-trade agreement with Canada?

However, Villani adds, “ Its early days, the situation is still very fluid,  the requisite notice under Article 50 of the Treaty on European Union has not been sent by the UK government, the UK still has a long way to go to actually extricate itself from the EU ” says Mr. Villani, adding that it could take more than two years for a separation to happen.

The BQBC is committed to promoting trade and commerce between Quebec and the UK and it will ensure that its members are informed as to developments in a coherent and unbiased fashion.

PERSONALIZED MEDICINE CONFERENCE PRESS RELEASE

Press Release

Personalized Medicine Conference

August 28, 2014

Quebec and British Healthcare Experts to Explore the Future of Personalized Medicine

Montreal, August 27, 2014 – Six panels comprised of more than 20 health care experts from the U.K. and Canada will meet on September 9th, 2014 at the Montreal Neurological Institute to discuss the topic: Personalized Health Care – Aligning the Business of Health Care.

Insights from both sides of the Atlantic could prove invaluable in how business, science and clinical practitioners come together to develop new and crucial medicines based on a personalized approach.

Panellists include clinical practitioners, government representatives, legal/regulatory affairs officers, advisors, industry representatives and researchers in order to include the viewpoints from all of the important participants in healthcare, up to and including the patient.

Representatives of Great Britain’s National Health Service (NHS) and National Institute for Health and Care Excellence (NICE), and influential healthcare professionals from our market, including a significant proportion of senior executive women, will outline the challenges and opportunities associated with developing and implementing personalized treatments.

“Personalized medicine has the potential to radically change medical practice by transforming the way we manage our own health and the healthcare system as a whole. Important challenges exist in how it will be deployed in a coherent equitable system that meets population needs.”  Says Howard Bergman MD, FCFP, FRCPC, Department Chair and Professor of Family Medicine, and first Dr. Joseph Kaufmann Professor of Geriatric Medicine at McGill University.

Sponsors

Stay Connected

Facebook
Twitter
LinkedIn